Thrombolysis increases the risk of persistent headache attributed to ischemic stroke: A prospective observational study.

Abstract

Persistent headache attributed to ischemic stroke (PHPIS) is increasingly acknowledged and was added to the 2018 ICHD-3. Intravenous thrombolysis (IVT) is a common treatment for acute ischemic stroke. It remains unknown whether this treatment influences the occurrence of a persistent poststroke headache. We aimed to describe the incidence and clinical characteristics of persistent headaches occurring after acute ischemic stroke in patients with or without IVT and explore the risk factors. A prospective observational study was performed between the 234 individuals who received IVT and 226 individuals without IVT in 5 stroke units from Wuhan, China. Subjects were followed for 6 months after stroke via a structured questionnaire. Age, gender, vascular risk factors, and infarct location/ circulation distribution did not differ between the groups, although IVT group had higher initial NIHSS scores. At the end of the follow-up, 12.0% (55/460) of subjects reported persistent headaches after ischemic stroke. The prevalence of persistent headache was significantly higher in the IVT group than non-IVT group (15.4%vs. 8.4%, p=.021). Patients with younger age (p=.033; OR 0.97; 95% CI 0.939-0.997), female sex (p=.007; OR 2.40; 95% CI 1.269-4.520), posterior circulation infarct (p=.024; OR 2.19; 95% CI 1.110-4.311), and IVT (p=.005; OR 2.51; 95% CI 1.313-4.782) were more likely to develop persistent headache after ischemic stroke. The potential influence of IVT should be considered when assessing persistent poststroke headache. Future studies will investigate the underlying mechanisms.